| 1. |
World Health Organization (WHO). Global battle against cancer won't be won with treatment alone-effective prevention measures urgently needed to prevent cancer crisis. Cent Eur J Public Health, 2014, 22(1): 23, 28.
|
| 2. |
Cabrera R, Nelson DR. Review article: the management of hepatocellular carcinoma. Aliment Pharmacol Ther, 2010, 31(4): 461-476.
|
| 3. |
Schlachterman A, Craft WW Jr, Hilgenfeldt E, et al. Current and future treatments for hepatocellular carcinoma. World J Gastroenterol, 2015, 21(28): 8478-8491.
|
| 4. |
Kondrup J, Allison SP, Elia M, et al. ESPEN guidelines for nutrition screening 2002. Clin Nutr, 2003, 22(4): 415-421.
|
| 5. |
Lawton MP, Brody EM. Assessment of older people: self-maintaining and instrumental activities of daily living. Gerontologist, 1969, 9(3): 179-186.
|
| 6. |
Oken MM, Creech RH, Tormey DC, et al. “Toxicity and response criteria of the Eastern Cooperative Oncology Group”. Am J Clin Oncol, 1982, 5(6): 649-655.
|
| 7. |
Slavova-azmanova NS, Johnson CE, Platell C, et al. Preview of cancer multidisciplinary teams: is it acceptable in Australia? Med J Aust, 2015, 202(3): 144-147.
|
| 8. |
Nikolovski Z, Watters DA, Stupart D, et al. Colorectal multidisciplinary meetings: how do they affect the timeliness of treatment? ANZ J Surg, 2015 Apr 24. [Epub ahead of print].
|
| 9. |
Palmer G, Martling A, Cedermark B, et al. Preoperative tumour staging with multidisciplinary team assessment improves the outcome in locally advanced primary rectal cancer. Colorectal Dis, 2011, 13(12): 1361-1369.
|
| 10. |
Thomas M, Thépot S, Galic N, et al. Diversifying mechanisms in the on-farm evolution of crop mixtures. Mol Ecol, 2015, 24(12): 2937-2954.
|
| 11. |
Mathoulin-pélissier S, Chevreau C, Bellera C, et al. Adherence to consensus-based diagnosis and treatment guidelines in adult soft-tissue sarcoma patients: a French prospective population-based study. Ann Oncol, 2014, 25(1): 225-231.
|
| 12. |
Powell HA, Baldwin DR. Multidisciplinary team management in thoraciconcology: more than just a concept? Eur Respir J, 2014, 43(6): 1776-1786.
|
| 13. |
Lai CL, Yuen MF. Prevention of hepatitis B virus-related hepatocellular carcinoma with antiviral therapy. Hepatology, 2013, 57(1): 399-408.
|
| 14. |
Huang G, Lau WY, Shen F, et al. Preoperative hepatitis B virus DNA level is a risk factor for postoperative liver failure in patients who underwent partial hepatectomy for hepatitis B-related hepatocellular carcinoma. World J Surg, 2014, 38(9): 2370-2376.
|
| 15. |
中华医学会肝病学分会和感染病学分会. 慢性乙型肝炎防治指南(2010年版). 实用肝脏病杂志, 2011, 14(2): 81-89.
|
| 16. |
Liapi E, Geschwind JF. Transcatheter and ablative therapeutic approaches for solid malignancies. J Clin Oncol, 2007, 25(8): 978-986.
|
| 17. |
Lai EC, Lau WY. The continuing challenge of hepatic cancer in Asia. Surgeon, 2005, 3(3): 210-215.
|
| 18. |
Lau WY, Lai EC. Hepatocellular carcinoma: current management and recent advances. Hepatobiliary Pancreat Dis Int, 2008, 7(3): 237-257.
|
| 19. |
张江洲, 龙志雄. 肝癌立体定向精确放疗的临床应用进展. 中国普外基础与临床杂志, 2016, 23(1): 119-122.
|
| 20. |
Ni JY, Liu SS, Xu LF, et al. Transarterial chemoembolization combined with percutaneous radiofrequency ablation versus TACE and RFA monotherapy in the treatment for hepatocellular carcinoma: a meta-analysis. J Cancer Res Clin Oncol, 2013, 139(4): 653-659.
|
| 21. |
Fu Y, Zhao X, Yun Q, et al. Transarterial chemoembolization (TACE) plus percutaneous ethanol injection (PEI) for the treatment of unresectable hepatocellular carcinoma: a meta- analysis of randomized controlled trials. Int J Clin Exp Med, 2015, 8(7): 10388-10400.
|
| 22. |
Lau WY, Ho SK, Yu SC, et al. Salvage surgery following downstaging of unresectable hepatocellular carcinoma. Ann Surg, 2004, 240(2): 299-305.
|
| 23. |
Chan AC, Poon RT, Cheung TT, et al. Survival analysis of resectionversus radiofrequency ablation for intrahepatic recurrence after hepatectomy for hepatocellular carcinoma. World J Surg, 2012, 36(1): 151-156.
|
| 24. |
Cucchetti A, Piscaglia F, Cescon M, et al. Cost-effectiveness of hepatic resectionversus percutaneous radiofrequency ablation for early hepatocellular carcinoma. J Hepatol, 2013, 59(2): 300-307.
|
| 25. |
Xu J, Xu HY, Zhang Q, et al. HAb18G/CD147 functions in invasion and metastasis of hepatocellular carcinoma. Mol Cancer Res, 2007, 5(6): 605-614.
|
| 26. |
Wu L, Yang YF, Ge NJ, et al. Hepatic arterial iodine-131-labeled metuximab injection combined with chemoembolization for unresectable hepatocellular carcinoma: interim safety and survival data from 110 patients. Cancer Biother Radiopharm, 2010, 25(6): 657-663.
|
| 27. |
刘连新, 朱安龙, 陈炜, 等. 三氧化二砷对原发性肝癌的作用及其机理研究. 中华外科杂志, 2005, 43(1): 33-34.
|
| 28. |
Panaro F, Piardi T, Audet M, et al. Laparoscopic ultrasound-guided radiofrequency ablation as a bridge to liver transplantation for hepatocellular carcinoma: preliminary results. Transplant Proc, 2010, 42(4): 1179-1181.
|
